Usefulness of serum tryptase level as an independent biomarker for coronary plaque instability in a Chinese population.

[1]  Xiaobo Li,et al.  Tryptase promotes human monocyte-derived macrophage foam cell formation by suppressing LXRalpha activation. , 2010, Biochimica et biophysica acta.

[2]  M. Jauhiainen,et al.  Mast cells promote atherosclerosis by inducing both an atherogenic lipid profile and vascular inflammation , 2009, Journal of cellular biochemistry.

[3]  M. Watkins.  Critical Role of Mast Cell Chymase in Mouse Abdominal Aortic Aneurysm Formation , 2010 .

[4]  A. Linneberg,et al.  Factors influencing serum total tryptase concentrations in a general adult population , 2010, Clinical chemistry and laboratory medicine.

[5]  P. Libby,et al.  Critical Role of Mast Cell Chymase in Mouse Abdominal Aortic Aneurysm Formation , 2009, Circulation.

[6]  P. Kovanen,et al.  Activated Mast Cells Induce Endothelial Cell Apoptosis by a Combined Action of Chymase and Tumor Necrosis Factor-&agr; , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[7]  P. Kovanen.  Mast cells: multipotent local effector cells in atherothrombosis , 2007, Immunological reviews.

[8]  P. Libby,et al.  Mast cells promote atherosclerosis by releasing proinflammatory cytokines , 2007, Nature Medicine.

[9]  A. Zernecke,et al.  Perivascular Mast Cells Promote Atherogenesis and Induce Plaque Destabilization in Apolipoprotein E–Deficient Mice , 2007, Circulation.

[10]  B. Mroczko,et al.  Basal serum tryptase level correlates with severity of hymenoptera sting and age. , 2007, Journal of investigational allergology & clinical immunology.

[11]  P. Kovanen,et al.  Serum tryptase levels in acute coronary syndromes. , 2005, International journal of cardiology.

[12]  Sidney C. Smith,et al.  Mast cell tryptase: a new biomarker in patients with stable coronary artery disease. , 2005, Atherosclerosis.

[13]  D. Chi,et al.  The role of human mast cell-derived cytokines in eosinophil biology. , 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[14]  M. Åbrink,et al.  The Chymase, Mouse Mast Cell Protease 4, Constitutes the Major Chymotrypsin-like Activity in Peritoneum and Ear Tissue. A Role for Mouse Mast Cell Protease 4 in Thrombin Regulation and Fibronectin Turnover , 2003, The Journal of experimental medicine.

[15]  D. Kosior,et al.  Tryptase levels in patients after acute coronary syndromes: The potential new marker of an unstable plaque? , 2003, Clinical cardiology.

[16]  P. Kovanen,et al.  Mast Cell Chymase Induces Smooth Muscle Cell Apoptosis by a Mechanism Involving Fibronectin Degradation and Disruption of Focal Adhesions , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[17]  A. von Eckardstein,et al.  Mast Cell Tryptase Degrades HDL and Blocks Its Function as an Acceptor of Cellular Cholesterol , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[18]  O. David,et al.  Blood histamine is associated with coronary artery disease, cardiac events and severity of inflammation and atherosclerosis , 2002, Journal of cellular and molecular medicine.

[19]  K. Arakawa,et al.  Chymase inhibition suppresses high-cholesterol diet-induced lipid accumulation in the hamster aorta. , 2002, Cardiovascular research.

[20]  T. Theoharides,et al.  Acute stress induces cardiac mast cell activation and histamine release, effects that are increased in Apolipoprotein E knockout mice. , 2002, Cardiovascular research.

[21]  J. Keski‐Oja,et al.  Activation of paracrine TGF‐β1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  H. Crijns,et al.  No long-lasting or intermittent mast cell activation in acute coronary syndromes. , 2001, International journal of cardiology.

[23]  M. Ala-Korpela,et al.  Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions. , 2000, Journal of lipid research.

[24]  R. Levi,et al.  Angiotensin-converting enzyme-independent angiotensin formation in a human model of myocardial ischemia: modulation of norepinephrine release by angiotensin type 1 and angiotensin type 2 receptors. , 2000, The Journal of pharmacology and experimental therapeutics.

[25]  M. Majima,et al.  Chymase as a Proangiogenic Factor A POSSIBLE INVOLVEMENT OF CHYMASE-ANGIOTENSIN-DEPENDENT PATHWAY IN THE HAMSTER SPONGE ANGIOGENESIS MODEL* , 2000 .

[26]  C. May.  Mast cell heterogeneity in the human uvea , 1999, Histochemistry and Cell Biology.

[27]  G. Angelini,et al.  Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[28]  T. Nakahata,et al.  Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation. , 1998, Blood.

[29]  S. Takai,et al.  Induction of chymase that forms angiotensin II in the monkey atherosclerotic aorta , 1997, FEBS letters.

[30]  S. Ren,et al.  Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. , 1997, The Journal of clinical investigation.

[31]  D. Woolley,et al.  MAST CELL DISTRIBUTION, ACTIVATION, AND PHENOTYPE IN ATHEROSCLEROTIC LESIONS OF HUMAN CAROTID ARTERIES , 1997, The Journal of pathology.

[32]  F. Cunha,et al.  Role of resident mast cells and macrophages in the neutrophil migration induced by LTB4, fMLP and C5a des arg. , 1997, International archives of allergy and immunology.

[33]  P. Kovanen,et al.  Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha. , 1996, Circulation.

[34]  P. Kovanen,et al.  Mast cells accompany microvessels in human coronary atheromas: implications for intimal neovascularization and hemorrhage. , 1996, Atherosclerosis.

[35]  E Edston,et al.  Immunoglobulin E, mast cell-specific tryptase and the complement system in sudden death from coronary artery thrombosis. , 1995, International journal of cardiology.

[36]  P. Constantinides.  Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. , 1995, Circulation.

[37]  P. Kovanen,et al.  Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. , 1994, Circulation.

[38]  P. Kovanen,et al.  Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. , 1994, The Journal of biological chemistry.

[39]  K. Suzuki,et al.  Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. , 1989, The Journal of clinical investigation.

[40]  L. Schwartz,et al.  Two types of human mast cells that have distinct neutral protease compositions. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[41]  H. Seppä,et al.  Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G. , 1981, The Journal of biological chemistry.